Clinical Trial Update: Adj TC + Herceptin Early Stage Breast Cancer [Phase 2]

View source ↗

Summary

This clinical trial update concerns a Phase 2 study of adjuvant TC (docetaxel/cyclophosphamide) plus trastuzumab (Herceptin) in early-stage breast cancer. The t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DOCETAXEL (DOCETAXEL)
• HERCEPTIN (trastuzumab)

Snippet

Sponsor: US Oncology Research | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-11-03